GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Walvax Biotechnology Co Ltd (SZSE:300142) » Definitions » Price-to-Tangible-Book

Walvax Biotechnology Co (SZSE:300142) Price-to-Tangible-Book : 2.77 (As of May. 27, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Walvax Biotechnology Co Price-to-Tangible-Book?

As of today (2024-05-27), Walvax Biotechnology Co's share price is ¥13.54. Walvax Biotechnology Co's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was ¥4.89. Hence, Walvax Biotechnology Co's Price to Tangible Book Ratio of today is 2.77.

The historical rank and industry rank for Walvax Biotechnology Co's Price-to-Tangible-Book or its related term are showing as below:

SZSE:300142' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.7   Med: 12.31   Max: 1930
Current: 2.77

During the past 13 years, Walvax Biotechnology Co's highest Price to Tangible Book Ratio was 1930.00. The lowest was 2.70. And the median was 12.31.

SZSE:300142's Price-to-Tangible-Book is ranked worse than
57.36% of 863 companies
in the Drug Manufacturers industry
Industry Median: 2.31 vs SZSE:300142: 2.77

A closely related ratio is called PB Ratio. As of today, Walvax Biotechnology Co's share price is ¥13.54. Walvax Biotechnology Co's Book Value per Sharefor the quarter that ended in Mar. 2024 was ¥5.83. Hence, Walvax Biotechnology Co's P/B Ratio of today is 2.32.


Walvax Biotechnology Co Price-to-Tangible-Book Historical Data

The historical data trend for Walvax Biotechnology Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Walvax Biotechnology Co Price-to-Tangible-Book Chart

Walvax Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.03 11.12 12.85 8.48 4.83

Walvax Biotechnology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.13 5.34 4.70 4.83 3.14

Competitive Comparison of Walvax Biotechnology Co's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Walvax Biotechnology Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Walvax Biotechnology Co's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Walvax Biotechnology Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Walvax Biotechnology Co's Price-to-Tangible-Book falls into.



Walvax Biotechnology Co Price-to-Tangible-Book Calculation

Walvax Biotechnology Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=13.54/4.892
=2.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Walvax Biotechnology Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Walvax Biotechnology Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Walvax Biotechnology Co (SZSE:300142) Business Description

Traded in Other Exchanges
N/A
Address
Keyuan Road No. 99, 19th Floor, Building 9A, Dingyi Tiancheng Residential Quarter, High & New Tech Development Zone, Yunnan Province, Kunming, CHN, 650106
Walvax Biotechnology Co Ltd biological pharmaceutical enterprise engaged in research and development, production and sales of bio-medicine products. It offers bio-medicines, such as vaccines, blood products, and others. The company's products include Haemophilus influenza type b conjugate vaccines, freeze-dried group A, C meningococcal polysaccharide conjugate vaccines, group ACYW135 meningococcal polysaccharide vaccines, and group A and C meningococcal polysaccharide vaccines.
Executives
Wu Yun Yan Executives
Zhao Jin Long Executives
Yao Wei Executives
Zhou Hua Executives
Shi Jing Executives
Jiang Run Sheng Directors, executives
Gong Sun Qing Executives
Executives
Yuan Lin Executives
Fang Guo Liang Executives
Li Yun Chun Director
Huang Zhen Director
Zhang Li Secretary Dong
Yang Hong Wei Supervisors
Xu Ke Ren Executives

Walvax Biotechnology Co (SZSE:300142) Headlines

No Headlines